Nicotine exploits COPI to foster addiction

December 30, 2013
Chronic exposure to nicotine (bottom image) up-regulates fluorescently labeled receptors known as nACHRs (green) in the substantia nigra pars compacta (SNc) and ventral tegmental (VTA) areas of the mouse brain. Up-regulation of nAChRs plays a major role in nicotine addiction and, possibly, in the decreased susceptibility of smokers to Parkinson's disease. Credit: Henderson et al., 2014

A study in The Journal of General Physiology helps explain how nicotine exploits the body's cellular machinery to promote addiction. The findings could lead to new therapies to help people quit smoking.

According to the Center for Disease Control and Prevention, tobacco accounts for the greatest number of worldwide by any single agent. Nicotine, the of tobacco, activates receptors known as nAChRs and, remarkably, unlike most other drugs of abuse, it acts as a "pharmacological chaperone" to stabilize assembly of its receptors within the Endoplasmic Reticulum (ER) and increase their abundance at the cell surface (up-regulation). Up-regulation of nAChRs plays a major role in and, possibly, in the decreased susceptibility of smokers to Parkinson's disease.

Receptors containing an ∝6 subunit (∝6* nAChRs) are abundant in several specific brain regions. Researchers from the California Institute of Technology in Pasadena used mice expressing ∝6 labeled with a fluorescent protein to show that exposure to nicotine—at a level comparable to that in human smokers—up-regulated ∝6* nAChRs in these areas of the brain.

Unexpectedly, the researchers discovered that nicotine's ability to up-regulate ∝6* nAChRs relied on the retrograde transport of ∝6* nAChRs back from the Golgi to the ER by COPI-coated vesicles. The authors believe that Golgi–ER cycling (involving COPI vesicles) may be a common mechanism for up-regulation of other nAChRs by nicotine. Manipulation of this process could therefore help form new strategies for smoking cessation and neuroprotection against Parkinson's disease.

The video will load shortly
This video animation shows how nicotine acts as a chaperone for receptors called nAChRs in neurons, promoting their exit from the ER and eventually increasing their abundance at the plasma membrane. Nicotine-mediated activation of nAChRs also depends on the COPI machinery involved in Golgi–ER transport of nAChRs. The findings could help form new strategies for smoking cessation and neuroprotection against Parkinson's disease. Credit: Mary O'Reilly, O'Reilly Science Art

Explore further: Scientists reveal key mechanism governing nicotine addiction

More information: Henderson, B.J., et al. 2014. J. Gen. Physiol. DOI: 10.1085/jgp.201311102
Anand, R. 2014. J. Gen. Physiol. DOI: 10.1085/jgp.201311136

Related Stories

Scientists reveal key mechanism governing nicotine addiction

January 30, 2011

Scientists from the Florida campus of The Scripps Research Institute have identified a pathway in the brain that regulates an individual's vulnerability to the addictive properties of nicotine. The findings suggest a new ...

Want to stop smoking? See a specialist

December 20, 2013

Smokers in England who want to stop smoking are three times more likely to succeed if they see a trained advisor than if they try by themselves, according to a new study published online today in the medical journal Addiction. ...

Recommended for you

A new key in fighting Kennedy's disease

August 31, 2016

If a disease affects motoneurons, cells that control voluntary muscle activity, researchers should focus their efforts on motoneurons to find potential treatments, right?

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.